Technical Analysis for BOT - Botanix Pharmaceuticals Ltd
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Boomer Buy Setup | Bullish Swing Setup | -2.27% | |
Narrow Range Bar | Range Contraction | -2.27% | |
Narrow Range Bar | Range Contraction | -2.27% | |
Gapped Down | Weakness | -2.27% | |
Gapped Up | Strength | -4.44% | |
NR7 | Range Contraction | -2.27% | |
Narrow Range Bar | Range Contraction | -2.27% | |
Inside Day | Range Contraction | -2.27% |
Alert | Time |
---|---|
20 DMA Resistance | 1 day ago |
Boomer Buy Entry | 1 day ago |
Rose Above Previous Day's High | 1 day ago |
20 DMA Support | 1 day ago |
Outside Day | 1 day ago |
Get a Trading Assistant
Botanix Pharmaceuticals Ltd Description
Botanix Pharmaceuticals Limited, formerly Bone Medical Limited, is a pharmaceutical company. The Company focuses on developing medical dermatology products for dermatologists and their patients. Its segments include Research & Development and Corporate. The Company's products and pipeline products are all based on drug delivery technology known as Permetrex, which helps solve the challenge of delivering active pharmaceutical ingredients across the skin. The Company's products, which are under development, are focused on modulating the body's endocannabinoid system of receptors which regulates skin function, growth and renewal. Its product pipeline includes BTX1503, BTX1308 and BTX1204. Its BTX1503 is a transdermal gel formulation used for the treatment of serious acne in adults and teenagers. Its BTX1308 is a transdermal gel formulation used for the treatment of plaque psoriasis. Its BTX1204 is a transdermal gel formation used for the treatment of atopic dermititis.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Pharmaceuticals Health Sciences Rex Drug Delivery Pharmacology Acne Transdermal Active Pharmaceutical Ingredients Dermatology Psoriasis Routes Of Administration
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 0.24 |
52 Week Low | 0.076 |
Average Volume | 2,605,465 |
200-Day Moving Average | 0.169 |
50-Day Moving Average | 0.200 |
20-Day Moving Average | 0.220 |
10-Day Moving Average | 0.215 |
Average True Range | 0.011 |
RSI (14) | 51.69 |
ADX | 33.64 |
+DI | 26.111 |
-DI | 11.825 |
Chandelier Exit (Long, 3 ATRs) | 0.208 |
Chandelier Exit (Short, 3 ATRs) | 0.222 |
Upper Bollinger Bands | 0.242 |
Lower Bollinger Band | 0.199 |
Percent B (%b) | 0.38 |
BandWidth | 19.337 |
MACD Line | 0.005 |
MACD Signal Line | 0.006 |
MACD Histogram | -0.0013 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.230 | ||||
Resistance 3 (R3) | 0.232 | 0.228 | 0.228 | ||
Resistance 2 (R2) | 0.228 | 0.225 | 0.228 | 0.227 | |
Resistance 1 (R1) | 0.222 | 0.222 | 0.220 | 0.220 | 0.226 |
Pivot Point | 0.218 | 0.218 | 0.218 | 0.218 | 0.218 |
Support 1 (S1) | 0.212 | 0.215 | 0.210 | 0.210 | 0.204 |
Support 2 (S2) | 0.208 | 0.212 | 0.208 | 0.203 | |
Support 3 (S3) | 0.202 | 0.208 | 0.203 | ||
Support 4 (S4) | 0.200 |